Merck
MRK
#48
Rank
NZ$486.93 B
Marketcap
NZ$196.95
Share price
-0.24%
Change (1 day)
20.31%
Change (1 year)

Market capitalization of Merck (MRK)

Market cap: NZ$486.93 Billion

As of March 2026 Merck has a market cap of NZ$486.93 Billion. This makes Merck the world's 48th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Merck from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$486.93 B5.73%
2025NZ$460.52 B2.98%
2024NZ$447.19 B2.37%
2023NZ$436.84 B-1.4%
2022NZ$443.06 B56.33%
2021NZ$283.42 B-1.19%
2020NZ$286.82 B-16.35%
2019NZ$342.88 B16.1%
2018NZ$295.32 B36.81%
2017NZ$215.85 B-7.88%
2016NZ$234.32 B9.17%
2015NZ$214.63 B4.34%
2014NZ$205.71 B15.37%
2013NZ$178.30 B18.38%
2012NZ$150.62 B2.31%
2011NZ$147.22 B2.26%
2010NZ$143.98 B-7.92%
2009NZ$156.36 B41.19%
2008NZ$110.75 B-32.8%
2007NZ$164.81 B22.85%
2006NZ$134.15 B32.12%
2005NZ$101.54 B2.08%
2004NZ$99.48 B-37%
2003NZ$157.90 B-35.16%
2002NZ$243.52 B-25.45%
2001NZ$326.63 B-33%
2000NZ$487.52 B62.81%
1999NZ$299.43 B-9.35%
1998NZ$330.32 B51.5%
1997NZ$218.03 B60.33%
1996NZ$135.98 B

End of Day market cap according to different sources

On Mar 8th, 2026 the market cap of Merck was reported to be:

NZ$486.93 Billion
by Nasdaq info icon info icon
NZ$486.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$985.39 B 102.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$526.46 B 8.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$261.62 B-46.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$323.81 B-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.507 T 209.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$338.82 B-30.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$183.00 B-62.42%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$208.83 B-57.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$185.78 B-61.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$61.50 B-87.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel